EGFR/HER2 exon 20 insertion mutation

Clinical trials for EGFR/HER2 exon 20 insertion mutation explained in plain language.

Never miss a new study

Get alerted when new EGFR/HER2 exon 20 insertion mutation trials appear

Sign up with your email to follow new studies for EGFR/HER2 exon 20 insertion mutation, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New pill takes aim at tough lung cancer mutations

Disease control Recruiting now

This study tests an experimental oral drug called STX-721 in people with advanced non-small cell lung cancer that has specific EGFR or HER2 gene mutations. The trial has three parts: first finding a safe dose, then confirming the best dose, and finally expanding to more participa…

Matched conditions: EGFR/HER2 EXON 20 INSERTION MUTATION

Phase 1/2 • Sponsor: Pierre Fabre Medicament • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC

EGFR/HER2 exon 20 insertion mutation

Get alerted when new EGFR/HER2 exon 20 insertion mutation trials appear

New pill takes aim at tough lung cancer mutations